Selected article for: "cell response and IFN type expression"

Author: Dean, Matthew J.; Ochoa, Juan B.; Sanchez-Pino, Maria Dulfary; Zabaleta, Jovanny; Garai, Jone; Del Valle, Luis; Wyczechowska, Dorota; Baiamonte, Lyndsey Buckner; Philbrook, Phaethon; Majumder, Rinku; Vander Heide, Richard S.; Dunkenberger, Logan; Thylur, Ramesh Puttalingaiah; Nossaman, Bobby; Roberts, W. Mark; Chapple, Andrew G.; Wu, Jiande; Hicks, Chindo; Collins, Jack; Luke, Brian; Johnson, Randall; Koul, Hari K.; Rees, Chris A.; Morris, Claudia R.; Garcia-Diaz, Julia; Ochoa, Augusto C.
Title: Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells
  • Cord-id: tzsbtxvu
  • Document date: 2021_7_14
  • ID: tzsbtxvu
    Snippet: COVID-19 ranges from asymptomatic in 35% of cases to severe in 20% of patients. Differences in the type and degree of inflammation appear to determine the severity of the disease. Recent reports show an increase in circulating monocytic-myeloid-derived suppressor cells (M-MDSC) in severe COVID 19 that deplete arginine but are not associated with respiratory complications. Our data shows that differences in the type, function and transcriptome of granulocytic-MDSC (G-MDSC) may in part explain the
    Document: COVID-19 ranges from asymptomatic in 35% of cases to severe in 20% of patients. Differences in the type and degree of inflammation appear to determine the severity of the disease. Recent reports show an increase in circulating monocytic-myeloid-derived suppressor cells (M-MDSC) in severe COVID 19 that deplete arginine but are not associated with respiratory complications. Our data shows that differences in the type, function and transcriptome of granulocytic-MDSC (G-MDSC) may in part explain the severity COVID-19, in particular the association with pulmonary complications. Large infiltrates by Arginase 1(+) G-MDSC (Arg(+)G-MDSC), expressing NOX-1 and NOX-2 (important for production of reactive oxygen species) were found in the lungs of patients who died from COVID-19 complications. Increased circulating Arg(+)G-MDSC depleted arginine, which impaired T cell receptor and endothelial cell function. Transcriptomic signatures of G-MDSC from patients with different stages of COVID-19, revealed that asymptomatic patients had increased expression of pathways and genes associated with type I interferon (IFN), while patients with severe COVID-19 had increased expression of genes associated with arginase production, and granulocyte degranulation and function. These results suggest that asymptomatic patients develop a protective type I IFN response, while patients with severe COVID-19 have an increased inflammatory response that depletes arginine, impairs T cell and endothelial cell function, and causes extensive pulmonary damage. Therefore, inhibition of arginase-1 and/or replenishment of arginine may be important in preventing/treating severe COVID-19.

    Search related documents:
    Co phrase search for related documents
    • abcam dilution and lysis buffer: 1, 2, 3
    • abcam dilution and ma cambridge: 1, 2, 3, 4
    • abcam dilution and ma cambridge abcam: 1, 2, 3, 4
    • abcam dilution and ma cambridge abcam dilution: 1, 2, 3, 4
    • accession number and additional analysis: 1
    • accession number and low expression: 1
    • accession number and lung tissue: 1